ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 120 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,288,000 | +77.9% | 2,800,000 | +100.0% | 0.96% | -18.0% |
| Q2 2020 | $20,398,000 | +62.1% | 1,400,000 | -5.3% | 1.17% | +55.4% |
| Q1 2020 | $12,584,000 | -74.1% | 1,478,753 | -49.9% | 0.75% | -69.6% |
| Q4 2019 | $48,587,000 | +16.6% | 2,950,000 | 0.0% | 2.47% | +12.9% |
| Q3 2019 | $41,654,000 | +3.6% | 2,950,000 | +47.5% | 2.19% | +16.8% |
| Q2 2019 | $40,220,000 | -49.4% | 2,000,000 | 0.0% | 1.88% | -52.7% |
| Q1 2019 | $79,500,000 | +20.4% | 2,000,000 | +5.3% | 3.96% | +26.5% |
| Q4 2018 | $66,006,000 | -1.5% | 1,900,000 | +17.3% | 3.13% | +9.2% |
| Q3 2018 | $66,987,000 | +12.5% | 1,620,000 | 0.0% | 2.87% | +25.1% |
| Q2 2018 | $59,535,000 | -5.6% | 1,620,000 | +0.2% | 2.29% | -26.0% |
| Q1 2018 | $63,051,000 | +550.5% | 1,616,690 | +201.9% | 3.10% | +553.2% |
| Q4 2017 | $9,693,000 | +9.4% | 535,500 | 0.0% | 0.47% | -15.7% |
| Q3 2017 | $8,863,000 | +18.2% | 535,500 | 0.0% | 0.56% | +54.0% |
| Q2 2017 | $7,497,000 | +191.8% | 535,500 | +328.4% | 0.36% | +251.0% |
| Q1 2017 | $2,569,000 | – | 125,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |